Pharmacy benefit managers (PBMs) took $123.5 million in spread pricing from Kentucky Medicaid plans, according to a state report; Richard Sackler, MD, the former president of OxyContin maker Purdue Pharma, repeatedly gave testimony in an opioid lawsuit that conflicts with a federal report, according to court papers; rural state lawmakers in Kansas are pushing a plan to allow the Farm Bureau to offer health insurance coverage, but Democrats and others are critical of the idea.
Pharmacy benefit managers (PBMs) took $123.5 million in spread pricing from Kentucky Medicaid plans, according to a state report. Bloomberg reported that 4 Kentucky insurers in Medicaid paid $957.7 million to 4 PBMs that use the arrangements last year. Of that, the PBMs kept 13% through spread pricing, and the size of the spreads rose by more than a third from 2017, the state found. Reports from other states have found similar patterns.Richard Sackler, MD, the former president of OxyContin maker Purdue Pharma, repeatedly gave testimony in an opioid lawsuit that conflicts with a federal report, according to court papers obtained by ProPublica and STAT News. The court papers that indicate Sackler endorsed marketing efforts to conceal the opioid’s strength from physicians as soon as a year after the drug's 1996 launch. During a previous pretrial deposition he said he first learned from a Maine newspaper article in 2000 that the painkiller was being abused.Rural state lawmakers in Kansas are pushing a plan to allow the Farm Bureau to offer health insurance coverage to members without having to comply with Affordable Care Act mandates in hopes that the agriculture group's plan will have a lower price, the Associated Press reported. But the proposal is drawing strong criticism from Democrats and health groups because a Farm Bureau plan would not be required to cover people with pre-existing medical conditions.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More